Derangements of cardiac NKA isoforms have long been described in major cardiovascular diseases, including cardiomyopathies and heart failure [40,42,43,44,45,46], yet in most cases the underlying mechanisms and functional consequences of those changes remain incompletely understood. This evidence concerns the gene TAC1 and cardiovascular disorder.